SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about record date for redemption of CP

18 Feb 2021 Evaluate

Pursuant to SEBI circular no. SEBI/HO/DDHS/CIR/P/2019/115 dated October 22 2019, Sun Pharmaceutical Industries has informed that Thursday, February 25, 2021 is the record date to determine the holders of Commercial Papers (CPs) of the Company whose names stand registered in the Register of Beneficial Owners maintained by Depositories in respect of the CPs held in electronic form under ISIN No. INE044A14625 and who are entitled to receive payment towards redemption amount on the Maturity Date February 26, 2021. The record date and further details are enclosed.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma. Inds. Share Price

1862.70 -9.90 (-0.53%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: